Dangge Wang
Impact in
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
- Biomedical Engineering top 0.5%
- Nanoplatforms for cancer theranostics
Papers in
-
- Nanoplatforms for cancer theranostics 35
- Immunology 25
- Immunotherapy and Immune Responses 18
- Immune cells in cancer 8
- Co-authors
- Yaping Li (44 shared papers)Haijun Yu (24 shared papers)Bing Feng (20 shared papers)Fangyuan Zhou (16 shared papers)Lei Zhou (9 shared papers)Zhiwen Zhang (14 shared papers)Tingting Wang (6 shared papers)Yuting Ma (2 shared papers)
In The Last Decade
Dangge Wang
52 papers receiving 5.0k citations
Dangge Wang's Hit Papers
Peers
Comparison fields: 5 of 108
- Biomaterials 1.6k
- Biomedical Engineering 3.3k
- Immunology 1.5k
- Oncology 881
- Molecular Biology 1.5k
Countries citing papers authored by Dangge Wang
This map shows the geographic impact of Dangge Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dangge Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dangge Wang more than expected).
Fields of papers citing papers by Dangge Wang
This network shows the impact of papers produced by Dangge Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dangge Wang. The network helps show where Dangge Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Dangge Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor Microenvironment‐Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade Hit paper breakdown → | 2019 | 462 |
| 2 | Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment Hit paper breakdown → | 2018 | 411 |
| 3 | Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy Hit paper breakdown → | 2016 | 380 |
| 4 | 2018 | 358 | |
| 5 | 2012 | 327 | |
| 6 | 2013 | 322 | |
| 7 | 2016 | 269 | |
| 8 | 2019 | 228 | |
| 9 | 2017 | 149 | |
| 10 | 2014 | 144 | |
| 11 | 2020 | 132 | |
| 12 | 2020 | 124 | |
| 13 | 2017 | 117 | |
| 14 | 2020 | 111 | |
| 15 | 2016 | 109 | |
| 16 | 2022 | 104 | |
| 17 | 2017 | 91 | |
| 18 | 2015 | 87 | |
| 19 | 2020 | 86 | |
| 20 | 2017 | 81 |
About Dangge Wang
Dangge Wang is a scholar working on Biomedical Engineering, Immunology, Biomaterials, Oncology and Molecular Biology, having authored 54 papers that have together received 5.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (35 papers), Nanoparticle-Based Drug Delivery (19 papers), Immunotherapy and Immune Responses (18 papers), RNA Interference and Gene Delivery (10 papers), Cancer Immunotherapy and Biomarkers (10 papers), Immune cells in cancer (8 papers), Photodynamic Therapy Research Studies (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Biomaterials (1.6k citations), Biomedical Engineering (3.3k citations), Immunology (1.5k citations), Oncology (881 citations) and Molecular Biology (1.5k citations). Dangge Wang has collaborated with scholars based in China, Norway and Germany. Frequent co-authors include Yaping Li, Haijun Yu, Bing Feng, Fangyuan Zhou, Lei Zhou, Zhiwen Zhang, Tingting Wang, Yuting Ma, Qi Yin and Tingting Wang. Their work appears in journals such as Advanced Functional Materials, Advanced Materials, Nano Letters, Biomaterials and Acta Pharmacologica Sinica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.